论文部分内容阅读
本文较为详尽地介绍了作者把氯丙嗪引入北美,并用于精神病治疗的过程。作者由欧洲来到了位于北美洲的加拿大,在蒙特利尔的一所条件简陋的医院从事精神病的研究与治疗工作。作者认为与某些情感受累的神经功能性疾病不同,精神分裂症具有一定的生化基础,据此进行了各种药物实验。例如:大剂量咖啡因治疗木僵性精神分裂症,结果收效甚微。用氧化亚氯治疗抑郁性精神病,并以本人及同事作为对照者,对比用药后脑电图改善情况,但结果证明氧化亚氯可能是人们所感兴趣的实验性睡眠诱导剂,但用于精神病治疗远为不足。也曾使用过代号为407的垂体提取物,但仍以
This article describes in more detail the author’s introduction of chlorpromazine into North America and its use in psychiatric treatment. The author traveled from Europe to Canada in North America to research and treat psychiatric conditions in a curt condition hospital in Montreal. The author believes that with certain emotional involvement of neurological diseases, schizophrenia has a certain biochemical basis, based on which a variety of drug experiments. For example: high-dose caffeine treatment of wooden schizophrenia, with little success. The use of chlorine dioxide in the treatment of depressive psychosis, and I and colleagues as a control, to compare the improvement of electroencephalogram after treatment, but the results show that chlorine dioxide may be interested in experimental sleep inducer, but for the treatment of psychiatric far Not enough. Pituitary extract code 407 has also been used, but still